← Eichor
Study identifier: NCT06461000 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey

Condition: Rheumatologic Disease · Musculoskeletal Diseases  ·  Sponsor: European Alliance of Associations in Rheumatology

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The EULAR Impact of RMDs Survey collects first-hand information about the impact of rheumatic and musculoskeletal diseases (RMDs) among patients across and beyond Europe. Through periodic questionnaires, patients will provide information about their healthcare situation, and how the disease affects their social and occupational lives. This data will be an important resource for researchers, healthcare professionals, and patients alike, providing valuable insights into the burden of disease and helping improve the overall care for people living with these conditions.

This description comes directly from the study's public registry record.

Talk to the study team

Coralie Signorell, PhD  ·  0445751564  ·  coralie.signorell@eular.org

Carina Haupt  ·  +41 44 716 30 46  ·  carina.haupt@eular.org

Always discuss trial participation with your own doctor first.

Locations (1)

EULARKilchberg, Canton of Zurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06461000